Jim Reddoch - Chief Scientific Officer, Executive Vice President, Head of Research and Investments @ Royalty Pharma

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

Primary Job Title Chief Scientific Officer, Executive Vice President, Head of Research and Investments
Primary Organization
Royalty Pharma

Jim Reddoch is the Chief Scientific Officer and EVP, Research & Investments, Royalty Pharma

Number of Current Jobs

has

current jobs including

Therapy Acceleration Program (TAP)

External Review Committee, Technology Development Fund

, and

Chief Scientific Officer, Executive Vice President, Head of Research and Investments

Blood Cancer United, Inc. Therapy Acceleration Program (TAP)May 2021
Memorial Sloan - Kettering Cancer Center External Review Committee, Technology Development FundApr 2014
Royalty Pharma Chief Scientific Officer, Executive Vice President, Head of Research and InvestmentsJul 2008

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Pharmaceutical Public Companies With More Than $50M in Revenue	37,849
Greater New York Area Public Companies With More Than $1B in Revenue	27,431
Pharmaceutical Companies With More Than $100M in Revenue	11,321
Northeastern US Public Companies With Fewer Than 1000 Employees	33,934
City of New York Public Companies With More Than $50M in Revenue	52,428
Northeastern US Public Companies With More Than $500 in Revenue	15,684
East Coast Accelerators	51,510
Accelerators with Investments in East Coast	19,016
City of New York Pharmaceutical Companies	51,032
City of New York Companies With More Than $500 in Revenue	14,924

studied at

There is no recent news or activity for this profile.